Sequential Study of Plasma Euglobulin Fibrinolytic Activity during the Normal Menstrual Cycle and in Women on Oral Contraceptives Low in Estrogen
- 1 January 1983
- journal article
- research article
- Published by S. Karger AG in Gynecologic and Obstetric Investigation
- Vol. 15 (5) , 266-274
- https://doi.org/10.1159/000299420
Abstract
Determinations of plasma euglobulin fibrinolytic activity were made in samples of plasma collected during one normal or hormone-simulated cycle in 15 young, normal women and in 11 women using an oral contraceptive low in estrogen. Distinct, individual levels caused the variations of fibrinolytic activity to be larger within the group than individually, and the activity showed only small changes during the cycle. The hormone group showed a marked increase in fibrinolytic activity with distinct fluctuations related to the phase of the cycle. This increase corresponded to that previously reported to be caused by oral contraceptives containing higher concentrations of estrogen.Keywords
This publication has 6 references indexed in Scilit:
- Observations during the treatment of antithrombin-III deficient women with heparin and antithrombin concentrate during pregnancy, parturition, and abortionThrombosis Research, 1981
- Termination of Pregnancy in a Woman with Hereditary Antithrombin Deficiency under Antithrombotic Protection with Subcutaneous Heparin and Infusion of PlasmaGynecologic and Obstetric Investigation, 1981
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980
- HÆMOSTATIC, LIPID, AND BLOOD-PRESSURE PROFILES OF WOMEN ON ORAL CONTRACEPTIVES CONTAINING 50 µg OR 30 µg ŒSTROGENThe Lancet, 1977
- Blood coagulation, fibrinolysis, and contraceptive hormonesJAMA, 1967
- A Comparative Study of Coagulation and Fibrinolysis in Blood from Normal Men and WomenBritish Journal of Haematology, 1966